… , the proportion of participants who withdrew due to adverse events … adults [105, 106], and
contributed to the retraction of a 2014 Cochrane review of methylphenidate for ADHD in adults …

… 2015 Cochrane review by Storebø and colleagues [6,7]. In this article, we consider the effects
of methylphenidate in … of good quality from our search mentioned the effects of withdrawal …

… the review. SR protocols and those marked as “withdrawn” from the Cochrane Library were
… the studies included in the reviews, for example, in the methylphenidate review, in which only …

… psychostimulants (eg, methylphenidate and amphetamines) and … PubMed, Cochrane Library,
and Embase databases were … -blind, placebo-controlled withdrawal trials of medications for …

… assessed the risk of bias utilizing the Cochrane Collaboration’s tool criteria. Differences
were … When analyzing withdrawal resulting from adverse events and all-cause treatment …

… that the need for continued treatment be reviewed annually (1, 6–… patients may be withdrawn
from methylphenidate without … Cochrane Database Syst Rev 2015; (11): CD009885 Medline…

… In the analyses, we will lump methylphenidate and … by the proportion of patients who withdrew
from the study for any … in our NMA will be assessed using the Cochrane Risk of Bias tool-…

… A review of guidelines based on evidence for the pharmacological treatment of ADHD in
children, adolescents, and adults considers psychostimulants such as methylphenidate and …

… Cochrane Collaboration withdraws a review on immediate-release methylphenidate for
adults with attention deficit hyperactivity disorder. Evid Based Med 2017;22:143–7. …

… of randomised placebo-controlled withdrawal trials and large … psychostimulants (eg,
methylphenidate and amphetamines) … of bias of individual studies with the Cochrane risk of bias …